Related Experiment Video
Updated: Feb 10, 2026

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
Successful Treatment of Protein-Losing Enteropathy and Plastic Bronchitis by Biphasic Cuirass Ventilation in a
Seigo Okada1, Jun Muneuchi1, Yusaku Nagatomo1
1Department of Pediatrics, Japan Community Healthcare Organization, Kyushu Hospital.
Insights
Biphasic cuirass ventilation (BCV) effectively treated protein-losing enteropathy and plastic bronchitis in a patient with hypoplastic left heart syndrome after a Fontan operation. BCV improved clinical symptoms and increased stroke volume, suggesting its potential for failing Fontan circulation.
Area of Science:
- Cardiology
- Pediatric Cardiology
- Thoracic Surgery
Background:
- Hypoplastic left heart syndrome (HLHS) is a complex congenital heart defect requiring surgical palliation.
- The Fontan operation is a common procedure for HLHS, but complications like protein-losing enteropathy (PLE) and plastic bronchitis (PB) can arise.
- Medical therapies for PLE and PB post-Fontan have shown limited efficacy.
Observation:
- A 16-year-old male with HLHS developed refractory PLE and PB after a Fontan procedure.
- Standard medical treatments including albumin, heparin, and anti-aldosterone therapy provided no relief.
- The patient's condition significantly impacted his quality of life and cardiac function.
Findings:
- Biphasic cuirass ventilation (BCV) was initiated for plastic bronchitis, leading to expectoration of bronchial casts and rapid resolution of PB.
- Remarkably, concurrent clinical symptoms of protein-losing enteropathy also showed dramatic improvement with BCV.
- BCV therapy transiently increased stroke volume from 26±1.4 mL to 39±4.0 mL.
Implications:
- This case highlights BCV as a potential non-invasive therapeutic option for protein-losing enteropathy in patients with failing Fontan circulation.
- BCV may improve intrathoracic pressure dynamics, aiding in the management of fluid balance and lymphatic drainage in Fontan patients.
- Further research is warranted to explore the mechanisms and efficacy of BCV in managing complex post-Fontan complications.
Abstract:
We present a 16-year-old male patient with hypoplastic left heart syndrome who developed protein-losing enteropathy (PLE) and plastic bronchitis (PB) after a Fontan operation. He received medical therapies, including albumin infusion, unfractionated heparin, and high-dose anti-aldosterone therapy but could not obtain clinical relief. Biphasic cuirass ventilation (BCV) led to expectoration of bronchial casts and prompt resolution of PB. Notably, clinical symptoms related to PLE were dramatically improved after starting BCV. A brief period of BCV increased stroke volume from 26±1.4 to 39±4.0 mL. This case suggests that BCV could be an effective treatment for PLE in patients with failing Fontan circulation.
Related Concept Videos
Ecological Succession
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Plasticity
Plasticizers
Plasticizers function by using surface-active agents to create repulsive electrostatic forces between cement particles. This dispersion enhances the concrete's...
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Plastic Behavior

